| pubmed-article:2597234 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2597234 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:2597234 | lifeskim:mentions | umls-concept:C0032105 | lld:lifeskim |
| pubmed-article:2597234 | lifeskim:mentions | umls-concept:C0011263 | lld:lifeskim |
| pubmed-article:2597234 | lifeskim:mentions | umls-concept:C0003591 | lld:lifeskim |
| pubmed-article:2597234 | pubmed:issue | 2-3 | lld:pubmed |
| pubmed-article:2597234 | pubmed:dateCreated | 1990-1-12 | lld:pubmed |
| pubmed-article:2597234 | pubmed:abstractText | We examined 27 elderly patients with multi-infarct dementia developed on the basis of cerebral arteriosclerosis. The levels of plasma cholesterol and triglyceride in the patients were 177 +/- 48 and 91 +/- 27 mg/dl (mean +/- SD), respectively. Despite normal plasma lipid levels, the patients had significantly higher plasma apo B (102 +/- 30 vs. 82 +/- 21 mg/dl for controls, P less than 0.01) and lower plasma apo A-I levels (104 +/- 25 vs. 130 +/- 22 mg/dl for controls, P less than 0.01) than the controls. Isoelectric focusing of apo E showed a 2-fold higher relative frequency for the epsilon 4 allele in patients than in Japanese controls (20.8 vs. 8.6-11.7% of total, P less than 0.05). The patients with phenotypes of E4/4 (n = 1) and E4/3 (n = 8) had higher plasma cholesterol levels than those with E3/3 (n = 15) (196 +/- 45 vs. 169 +/- 43 mg/dl). The results indicate that the patients had abnormalities in plasma lipoprotein metabolism and this may contribute to the development of cerebral arteriosclerosis. | lld:pubmed |
| pubmed-article:2597234 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2597234 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2597234 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2597234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2597234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2597234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2597234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2597234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2597234 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2597234 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2597234 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:2597234 | pubmed:issn | 0021-9150 | lld:pubmed |
| pubmed-article:2597234 | pubmed:author | pubmed-author:TakakuFF | lld:pubmed |
| pubmed-article:2597234 | pubmed:author | pubmed-author:IshibashiSS | lld:pubmed |
| pubmed-article:2597234 | pubmed:author | pubmed-author:YamadaNN | lld:pubmed |
| pubmed-article:2597234 | pubmed:author | pubmed-author:MuraseTT | lld:pubmed |
| pubmed-article:2597234 | pubmed:author | pubmed-author:OhtomoEE | lld:pubmed |
| pubmed-article:2597234 | pubmed:author | pubmed-author:GotohdaTT | lld:pubmed |
| pubmed-article:2597234 | pubmed:author | pubmed-author:ShimanoHH | lld:pubmed |
| pubmed-article:2597234 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2597234 | pubmed:volume | 79 | lld:pubmed |
| pubmed-article:2597234 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2597234 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2597234 | pubmed:pagination | 257-60 | lld:pubmed |
| pubmed-article:2597234 | pubmed:dateRevised | 2004-11-17 | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:meshHeading | pubmed-meshheading:2597234-... | lld:pubmed |
| pubmed-article:2597234 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2597234 | pubmed:articleTitle | Plasma apolipoproteins in patients with multi-infarct dementia. | lld:pubmed |
| pubmed-article:2597234 | pubmed:affiliation | Third Department of Internal Medicine, University of Tokyo, Japan. | lld:pubmed |
| pubmed-article:2597234 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2597234 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2597234 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2597234 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2597234 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2597234 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:2597234 | lld:pubmed |
